CD8A and neoplasm: Green et al. (82) similarly reported increased prevalence of CD8+ tumor-infiltrating lymphocytes in patient breast cancer tumors that expressed low levels of the XRCC1, ATM, and BRCA1 proteins involved with DNA damage response.